Cardinal to buy private generic drug distributor for US$1.12 billion
Add BT as a preferred sourcePublished Fri, Jun 5, 2015 · 11:26 AM
[BENGALURU] Cardinal Health Inc said it would buy privately held drug distributor Harvard Drug Group for US$1.12 billion.
Cardinal said it expects the deal to add more than 15 US cents per share to adjusted earnings from continuing operations in 2016 and 17 US cents per share in 2017.
REUTERS
Share with us your feedback on BT's products and services
